dRx Capital backs exceptional entrepreneurs transforming healthcare through data and digital technology. The fund, backed by Novartis & Qualcomm, invests in technology platforms improving access to healthcare and reimagining the practice of medicine, with a focus on AI & ML, big data, R&D optimization, patient care, and pharma supply chain and commercialization.
dRx Capital currently has 25+ portfolio companies, including: Aktana, Animantis, Aspen RxHealth, Cala Health, Cota Health, Flywheel, Freenome, H1, Koneksa, Mekonos, NuvoAir, Omada, Pear Therapeutics, Peptone, RxVantage, SchoolCare, Science 37, SomaLogic, Vineti, Xealth.
Company Details
- Employees
- 8
- Address
- Ch-4056, Basel,switzerland
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- https://drxcapital.com/
- Keywords
- San Francisco.
- HQ
- Basel
Drx Capital Questions
Drx Capital's website is https://drxcapital.com/
Drx Capital's LinkedIn profile is https://www.linkedin.com/company/drxcapital
Drx Capital has
8 employees.
View email and phone details for 8
employees at Drx Capital.
Drx Capital's industry is
Venture Capital and Private Equity Principals
Drx Capital's top competitors are
Octave,
Holmusk,
Rxlightning,
Sofinnova Partners,
Qs1 Headquarters,
Guardtime,
Drx,
Tpg,
Atria Ventures,
Novartis.
Drx Capital's categories are Venture Capital and Private Equity Principals
